Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants (Scientific Reports, (2022), 12, 1, (12189), 10.1038/s41598-022-16365-2)

Yura Shin; Jeonghun Kim; Jong Hyeon Seok; Heedo Park; Hye Ran Cha; Si Hwan Ko; Jae Myun Lee; Man Seong Park; Jung Hwan Park

doi:10.1038/s41598-022-20913-1

Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants (Scientific Reports, (2022), 12, 1, (12189), 10.1038/s41598-022-16365-2)

Yura Shin, Jeonghun Kim, Jong Hyeon Seok, Heedo Park, Hye Ran Cha, Si Hwan Ko, Jae Myun Lee, Man Seong Park, Jung Hwan Park

Department of Biomedical Sciences

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original version of this Article, Jung-Hwan Park was incorrectly affiliated with ‘QuadMedicine R&D Centre, QuadMedicine Co., Ltd, Seongnam, Republic of Korea’. The correct affiliation is listed below. Department of BioNano Technology, Gachon University, Seongnam, Republic of Korea The original Article has been corrected.

Original language	English
Article number	16540
Journal	Scientific reports
Volume	12
Issue number	1
DOIs	https://doi.org/10.1038/s41598-022-20913-1
Publication status	Published - 2022 Dec

ASJC Scopus subject areas

General

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41598-022-20913-1

Cite this

Shin, Y., Kim, J., Seok, J. H., Park, H., Cha, H. R., Ko, S. H., Lee, J. M., Park, M. S., & Park, J. H. (2022). Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants (Scientific Reports, (2022), 12, 1, (12189), 10.1038/s41598-022-16365-2). Scientific reports, 12(1), [16540]. https://doi.org/10.1038/s41598-022-20913-1

Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants (Scientific Reports, (2022), 12, 1, (12189), 10.1038/s41598-022-16365-2). / Shin, Yura; Kim, Jeonghun; Seok, Jong Hyeon et al.
In: Scientific reports, Vol. 12, No. 1, 16540, 12.2022.

Research output: Contribution to journal › Comment/debate › peer-review

Shin, Y, Kim, J, Seok, JH, Park, H, Cha, HR, Ko, SH, Lee, JM, Park, MS & Park, JH 2022, 'Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants (Scientific Reports, (2022), 12, 1, (12189), 10.1038/s41598-022-16365-2)', Scientific reports, vol. 12, no. 1, 16540. https://doi.org/10.1038/s41598-022-20913-1

@article{f78c851a86064638a135ffa0772d951c,

title = "Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants (Scientific Reports, (2022), 12, 1, (12189), 10.1038/s41598-022-16365-2)",

abstract = "In the original version of this Article, Jung-Hwan Park was incorrectly affiliated with {\textquoteleft}QuadMedicine R&D Centre, QuadMedicine Co., Ltd, Seongnam, Republic of Korea{\textquoteright}. The correct affiliation is listed below. Department of BioNano Technology, Gachon University, Seongnam, Republic of Korea The original Article has been corrected.",

author = "Yura Shin and Jeonghun Kim and Seok, {Jong Hyeon} and Heedo Park and Cha, {Hye Ran} and Ko, {Si Hwan} and Lee, {Jae Myun} and Park, {Man Seong} and Park, {Jung Hwan}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1038/s41598-022-20913-1",

language = "English",

volume = "12",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants (Scientific Reports, (2022), 12, 1, (12189), 10.1038/s41598-022-16365-2)

AU - Shin, Yura

AU - Kim, Jeonghun

AU - Seok, Jong Hyeon

AU - Park, Heedo

AU - Cha, Hye Ran

AU - Ko, Si Hwan

AU - Lee, Jae Myun

AU - Park, Man Seong

AU - Park, Jung Hwan

PY - 2022/12

Y1 - 2022/12

N2 - In the original version of this Article, Jung-Hwan Park was incorrectly affiliated with ‘QuadMedicine R&D Centre, QuadMedicine Co., Ltd, Seongnam, Republic of Korea’. The correct affiliation is listed below. Department of BioNano Technology, Gachon University, Seongnam, Republic of Korea The original Article has been corrected.

AB - In the original version of this Article, Jung-Hwan Park was incorrectly affiliated with ‘QuadMedicine R&D Centre, QuadMedicine Co., Ltd, Seongnam, Republic of Korea’. The correct affiliation is listed below. Department of BioNano Technology, Gachon University, Seongnam, Republic of Korea The original Article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85139100390&partnerID=8YFLogxK

U2 - 10.1038/s41598-022-20913-1

DO - 10.1038/s41598-022-20913-1

M3 - Comment/debate

C2 - 36192424

AN - SCOPUS:85139100390

SN - 2045-2322

VL - 12

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 16540

ER -

Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants (Scientific Reports, (2022), 12, 1, (12189), 10.1038/s41598-022-16365-2)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this